866-997-4948(US-Canada Toll Free)

Biocartis SA - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Dec 2012

Category :

Surgical Equipment

No. of Pages : 26 Pages


Biocartis SA (Biocartis) is a molecular diagnostics company. The company is focused on fast and low-cost integrated molecular and immunodiagnostics based on its micro-technology platform. The company has developed and licensed a series of new technologies to build a broadly applicable diagnostics platform for low to highly multiplexed detection, quantification, and amplification of bio-analytes, including proteins, nucleic acids and small molecules. The company is headquartered at Lausanne, Switzerland.

This report is a source for data, analysis and actionable intelligence on the Biocartis SA portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Biocartis SA - Major Products and Services 5
Biocartis SA Pipeline Products by Equipment Type 6
Biocartis SA Pipeline Products by Development Stage 8
Biocartis SA Pipeline Products by Therapy Area 10
Biocartis SA Pipeline Products by Milestone Summary 12
Apollo System 13
Apollo System Product Status 13
Apollo System Product Description 13
Apollo System Product Patent Details 13
Apollo System - Neurological Disease Assay 15
Apollo System - Neurological Disease Assay Product Status 15
Apollo System - Neurological Disease Assay Product Description 15
Apollo System - Viral Infection 16
Apollo System - Viral Infection Product Status 16
Apollo System - Viral Infection Product Description 16
DMAT Platform 17
DMAT Platform Product Status 17
DMAT Platform Product Description 17
DMAT Platform Product Milestone 17
DMAT Platform Product Patent Details 18
DMAT Platform - Oncogene Panel Assay 19
DMAT Platform - Oncogene Panel Assay Product Status 19
DMAT Platform - Oncogene Panel Assay Product Description 19
SeptiCyte Triage 20
SeptiCyte Triage Product Status 20
SeptiCyte Triage Product Description 20
Biocartis SA - Key Competitors 21
Biocartis SA - Key Employees 22
Biocartis SA - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Biocartis SA, Recent Developments 24
Nov 30, 2011: Biocartis Appoints Nayan Gregory Parekh As CEO 24
Jul 06, 2011: Biocartis Appoints Hilde Windels As CFO 24
Jan 10, 2011: Biocartis Appoints Clark Harrison As COO 25

Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Table


Biocartis SA, Key Facts 1
Biocartis SA Key Pipeline Products by Equipment Type 1
Biocartis SA Key Pipeline Products by Therapy Area 1
Biocartis SA Key Pipeline Products by Development Stage 1
Biocartis SA, Key Facts 4
Biocartis SA, Major Products and Services 5
Biocartis SA Number of Pipeline Products by Equipment Type 6
Biocartis SA Pipeline Products by Equipment Type 7
Biocartis SA Number of Pipeline Products by Development Stage 8
Biocartis SA Pipeline Products by Development Stage 9
Biocartis SA Number of Pipeline Products by Therapy Area 10
Biocartis SA Pipeline Products by Therapy Area 11
Biocartis SA Number of Pipeline Products By Milestone Summary 12
Biocartis SA Pipeline Products by Milestone Summary 12
Apollo System - Product Status 13
Apollo System - Product Description 13
Apollo System - Patent Details1 13
Apollo System - Neurological Disease Assay - Product Status 15
Apollo System - Neurological Disease Assay - Product Description 15
Apollo System - Viral Infection - Product Status 16
Apollo System - Viral Infection - Product Description 16
DMAT Platform - Product Status 17
DMAT Platform - Product Description 17
DMAT Platform - Product Milestone 17
DMAT Platform - Patent Details1 18
DMAT Platform - Oncogene Panel Assay - Product Status 19
DMAT Platform - Oncogene Panel Assay - Product Description 19
SeptiCyte Triage - Product Status 20
SeptiCyte Triage - Product Description 20
Biocartis SA, Key Employees 22
Biocartis SA, Subsidiaries 23

List of Chart


Biocartis SA Key Pipeline Products by Equipment Type 1
Biocartis SA Pipeline Products by Equipment Type 6
Biocartis SA Pipeline Products by Development Stage 8
Biocartis SA Pipeline Products by Therapy Area 10
Biocartis SA Pipeline Products by Milestone Summary 12

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *